A prospective, multicenter, observational study of trastuzumab deruxtecan in elderly patients with HER2-positive gastric cancer: EN-COURAGE

Gastric cancer (GC) disproportionately affects the elderly, yet pivotal trials have provided inconsistent evidence regarding the efficacy of human epidermal growth factor receptor 2 (HER2)-targeted and immune-based therapies in this subgroup. Beyond chronological age, geriatric assessment (GA) and s...

Full description

Bibliographic Details

Published in:	ESMO Gastrointestinal Oncology
Main Authors:	Y. Narita, R. Kawabata, T. Ando, T. Arigami, H. Kawakami, A. Makiyama, R. Uozumi, Y. Fukuda, K. Muro
Format:	Article
Language:	English
Published:	Elsevier 2026-03-01
Subjects:	EN-COURAGE HER2-positive gastric cancer trastuzumab deruxtecan elderly patients geriatric assessment
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949819826000130